We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Genetic Mutation Identified in Childhood Brain Disorder

By LabMedica International staff writers
Posted on 21 Aug 2018
Print article
Image: A comparison of an unaffected brain and an affected brain with pachygyria (Photo courtesy of Case Western Reserve University School of Medicine).
Image: A comparison of an unaffected brain and an affected brain with pachygyria (Photo courtesy of Case Western Reserve University School of Medicine).
Pachygyria is characterized by abnormal movement of brain nerve cells, known as neurons, during development of the brain and nervous system and is caused by a breakdown in the fetal neuronal migration process due to genetic or possibly environmental influences.

During normal embryonic growth, immature cells that later develop into specialized nerve cells (neurons) normally migrate to the brain's surface, making several layers of cells. When this process is impaired, the cells do not migrate to their locations, resulting in too few cell layers and absence (agyria) or incomplete development (pachygyria) of gyri.

A team of global genetics experts led by those at Case Western Reserve University Medical School (Cleveland, OH, USA) have discovered a genetic mutation and the faulty development process it triggers, causing a debilitating brain-based disorder in children, known as pachygyria. The scientists used genetic sequencing to study three families affected by the disease, and discovered that children with pachygyria have a mutation in both copies of the alpha-N-catenin gene (CTNNA2), each alteration coming from one parent. The mutation leads to loss of CTNNA2, which the team then showed affected how nerve cells travel from their source of origin in the developing brain to their concluding destination in what eventually becomes the neocortex, a process called neuronal migration.

The investigators found that when CTNNA2 is absent due to genetic mutation, excessive amounts of Actin-Related Proteins (ARP2/3) bind to actin, ultimately disrupting the mechanisms needed for appropriate migrating and branching out of nerve cells. Specifically, resultants ARP2/3 over-activity leads to excessive branching, which impairs neuron growth and stability. The finding raises the possibility of genetic engineering through techniques such as CRISPR-Cas9.

In addition to uncovering a key gene responsible for pachygyria and describing how its mechanisms operate, the scientists discovered a variation of the condition. Typically in cases of pachygyria, either the front or back of the brain displays smooth, non-wrinkled brain surface features. In cases of normal brain development, these areas are convoluted, resembling cauliflower in appearance. In the three families studied, they discovered that both the front and back of the brain were smooth.

The authors concluded that their findings identify CTNNA2 as the first catenin family member with biallelic mutations in humans, causing a new pachygyria syndrome linked to actin regulation, and uncover a key factor involved in ARP2/3 repression in neurons. Ashleigh E. Schaffer, PhD, an assistant professor of genetics and lead author of the study, said, “Our finding that alpha-N-catenin mutations cause pachygyria is an important step in understanding how neuronal development is regulated. The fact that we found this unique feature of back and front smooth brain led us to conclude that a new gene, not previously linked to pachygyria, is responsible. This turned out to be the case,” The study was published on July 16, 2018, in the journal Nature Genetics.

Related Links:
Case Western Reserve University Medical School

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.